Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private

BSE2219.009.15 (+0.41 %)

PREV CLOSE ( ) 2209.85

OPEN PRICE ( ) 2208.30

BID PRICE (QTY) 2219.45 (40)

OFFER PRICE (QTY) 2222.95 (119)

VOLUME 2373

TODAY'S LOW / HIGH ( )2207.00 2250.00

52 WK LOW / HIGH ( )1603.05 2284.95

NSE2217.707.5 (+0.34 %)

PREV CLOSE( ) 2210.20

OPEN PRICE ( ) 2209.90

BID PRICE (QTY) 2217.50 (9)

OFFER PRICE (QTY) 2218.70 (32)

VOLUME 227353

TODAY'S LOW / HIGH( ) 2190.10 2250.30

52 WK LOW / HIGH ( )1603.5 2285.3

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-12 1976

Management Info

Arun Duggal - Chairman Aman Mehta - Managing Director

Registered Office

Address 302 , Iscon Mall,Star India Bazaar Building,Opp Jodhpur Brts Satellite,
Ahmedabad,
Gujarat-380015

Phone 022- 2482 2222

Email secretarial@jbpharma.com

Website www.jbpharma.com

Registrars Details

Datamatics Business Solutions Ltd.

Plot No. A 16 & 17,Part B Cross Lane,MIDC, Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

23Feb JB Chemicals & Pharmaceuticals informs
With refer to letter dated February 20, 2026, in relation to submission..

21Feb J.B. Chemicals & Pharmaceuticals infor
J.B. Chemicals & Pharmaceuticals has informed that it enclosed the P..

22Jan JB Chemicals & Pharmaceuticals inform
JB Chemicals & Pharmaceuticals has informed that the exchange has re..

22Jan JB Chemicals & Pharmaceuticals informs
JB Chemicals & Pharmaceuticals has informed that the exchange has re..

21Jan JB Chemicals & Pharmaceuticals informs
Pursuant to Regulation 30 read with Schedule III of the Listing Regulati..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 26
Net Profit	965.400000000001	6741
Gross Profit	1281	9027.3
Operating Profit	2051.7	11111.9
Net Sales	8364.3	38898.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kwality Pharma (BSE) 2498.25 (6.93%)	M.Cap ( in Cr)2592.23
Abbott India (BSE) 26250.00 (0.40%)	M.Cap ( in Cr)55811.29
Venus Remedies (BSE) 1682.35 (5.00%)	M.Cap ( in Cr)2248.80
Caplin Point Lab (BSE) 2331.00 (3.25%)	M.Cap ( in Cr)17748.73
Concord Biotech (BSE) 1344.85 (5.76%)	M.Cap ( in Cr)14069.31

Shareholding Pattern

	PROMOTERS	48.8%
	MUTUAL FUNDS/UTI	19%
	NON-INSTITUTION	13.48%
	FI/BANKS/INSURANCE	1.33%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Kotak Healthcare Fu...	3.52
PGIM India Healthca...	3.16
Aditya Birla SL Pha...	2.82
LIC MF Healthcare F...	2.82
Kotak MNC Fund-Reg(G)	2.73
Mirae Asset Healthc...	2.71
Sundaram LT Tax Adv...	2.57

Risk Disclosures on Derivatives

Smart Quotes

JB CHEMICALS & PHARMACEUTICALS LTD.